File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study

TitleUsing genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study
Authors
Keywords3-Hydroxyisobutyrate
Branch-chain amino acids
Diabetes
Ischemic heart disease
Mendelian randomization
Sex-specific
Issue Date20-Aug-2023
PublisherElsevier
Citation
Atherosclerosis, 2023, v. 381 How to Cite?
Abstract

Background and aims: Branch-chain amino acids (BCAAs) are linked to higher risk of diabetes, whilst the evidence on ischemic heart disease (IHD) is limited. Valine metabolite, 3-hydroxyisobutyrate (3-HIB), also plays an important role in metabolism, whilst its effect has been rarely examined. At the situation of no evidence from large trials, we assessed the role of BCAAs and 3-HIB in IHD and diabetes using Mendelian randomization to minimize confounding. Given their potential role in sex hormones, we also examined sex-specific associations.

Methods: We used genetic variants to predict BCAAs and 3-HIB, and obtained their associations with IHD and diabetes in large consortia and cohorts, as well as sex-specific association in the UK Biobank and DIAGRAM. We obtained and combined the Wald estimates using inverse variance weighting, and different analytic methods robust to pleiotropy.

Results: Genetically predicted BCAAs were associated with higher risk of IHD (odds ratio (OR) 1.19 per standard deviation (SD) increase in BCAAs, 95% confidence interval (CI) 1.05 to 1.35) and diabetes (OR 1.20, 95% CI 1.08 to 1.34). The associations with IHD were stronger in women (OR 1.23, 95% CI 1.03 to 1.48) than men (OR 0.96, 95% CI 0.83 to 1.10). 3-HIB was associated with higher risk of IHD (OR 1.43, 95% CI 1.17 to 1.73) but not diabetes, with no sex disparity.

Conclusion: BCAAs and 3-HIB are potential targets for prevention in IHD and/or diabetes. BCAAs may exert a sex-specific role in IHD. Consideration of the sex disparity and exploration of the underlying pathways would be worthwhile.

Keywords: 3-Hydroxyisobutyrate; Branch-chain amino acids; Diabetes; Ischemic heart disease; Mendelian randomization; Sex-specific.


Persistent Identifierhttp://hdl.handle.net/10722/331692
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 1.461
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhao, Jie V-
dc.contributor.authorFan, Bohan-
dc.contributor.authorBurgess, Stephen-
dc.date.accessioned2023-09-21T06:58:03Z-
dc.date.available2023-09-21T06:58:03Z-
dc.date.issued2023-08-20-
dc.identifier.citationAtherosclerosis, 2023, v. 381-
dc.identifier.issn0021-9150-
dc.identifier.urihttp://hdl.handle.net/10722/331692-
dc.description.abstract<p><strong>Background and aims: </strong>Branch-chain amino acids (BCAAs) are linked to higher risk of diabetes, whilst the evidence on ischemic heart disease (IHD) is limited. Valine metabolite, 3-hydroxyisobutyrate (3-HIB), also plays an important role in metabolism, whilst its effect has been rarely examined. At the situation of no evidence from large trials, we assessed the role of BCAAs and 3-HIB in IHD and diabetes using Mendelian randomization to minimize confounding. Given their potential role in sex hormones, we also examined sex-specific associations.</p><p><strong>Methods: </strong>We used genetic variants to predict BCAAs and 3-HIB, and obtained their associations with IHD and diabetes in large consortia and cohorts, as well as sex-specific association in the UK Biobank and DIAGRAM. We obtained and combined the Wald estimates using inverse variance weighting, and different analytic methods robust to pleiotropy.</p><p><strong>Results: </strong>Genetically predicted BCAAs were associated with higher risk of IHD (odds ratio (OR) 1.19 per standard deviation (SD) increase in BCAAs, 95% confidence interval (CI) 1.05 to 1.35) and diabetes (OR 1.20, 95% CI 1.08 to 1.34). The associations with IHD were stronger in women (OR 1.23, 95% CI 1.03 to 1.48) than men (OR 0.96, 95% CI 0.83 to 1.10). 3-HIB was associated with higher risk of IHD (OR 1.43, 95% CI 1.17 to 1.73) but not diabetes, with no sex disparity.</p><p><strong>Conclusion: </strong>BCAAs and 3-HIB are potential targets for prevention in IHD and/or diabetes. BCAAs may exert a sex-specific role in IHD. Consideration of the sex disparity and exploration of the underlying pathways would be worthwhile.</p><p><strong>Keywords: </strong>3-Hydroxyisobutyrate; Branch-chain amino acids; Diabetes; Ischemic heart disease; Mendelian randomization; Sex-specific.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofAtherosclerosis-
dc.subject3-Hydroxyisobutyrate-
dc.subjectBranch-chain amino acids-
dc.subjectDiabetes-
dc.subjectIschemic heart disease-
dc.subjectMendelian randomization-
dc.subjectSex-specific-
dc.titleUsing genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study-
dc.typeArticle-
dc.identifier.doi10.1016/j.atherosclerosis.2023.117246-
dc.identifier.scopuseid_2-s2.0-85169562042-
dc.identifier.volume381-
dc.identifier.isiWOS:001070582300001-
dc.identifier.issnl0021-9150-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats